In a filing, Insmed Inc revealed its Officer Flammer Martina M.D. acquired Company’s shares for reported $2.97 million on Feb 10 ’25. In the deal valued at $78.57 per share,37,828 shares were bought.
Then, Adsett Roger bought 42,975 shares, generating $3,376,752 in total proceeds.
Before that, Flammer Martina M.D. sold 33,055 shares. Insmed Inc shares valued at $2,674,150 were divested by the Chief Medical Officer at a price of $80.90 per share. As a result of the transaction, Flammer Martina M.D. now holds 138,053 shares, worth roughly $10.78 million.
Truist initiated its Insmed Inc [INSM] rating to a Buy in a research note published on April 23, 2024; the price target was $48. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid February with a ‘”an Outperform”‘ rating. Wells Fargo began covering INSM with “an Overweight” recommendation on December 08, 2023.
Price Performance Review of INSM
On Monday, Insmed Inc [NASDAQ:INSM] saw its stock fall -2.29% to $78.12. Over the last five days, the stock has gained 0.31%. Insmed Inc shares have risen nearly 13.15% since the year began. Nevertheless, the stocks have risen 169.47% over the past one year. While a 52-week high of $82.04 was reached on 02/06/25, a 52-week low of $21.92 was recorded on 01/10/25. SMA at 50 days reached $73.42, while 200 days put it at $66.28.
Levels Of Support And Resistance For INSM Stock
The 24-hour chart illustrates a support level at 76.50, which if violated will result in even more drops to 74.87. On the upside, there is a resistance level at 79.93. A further resistance level may holdings at 81.73. The Relative Strength Index (RSI) on the 14-day chart is 56.80, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.98, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 51.79%. Stochastics %K at 71.17% indicates the stock is a holding.
How much short interest is there in Insmed Inc?
A steep rise in short interest was recorded in Insmed Inc stocks on 2025-01-15, growing by 2.08 million shares to a total of 15.09 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 13.01 million shares. There was a rise of 13.78%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 26, 2023 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.
